1995
DOI: 10.1159/000150427
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis C Virus as a Causative Agent of Hepatocellular Carcinoma

Abstract: HCV infection has shown to be strongly linked to the development of hepatocellular carcinoma in epidemiological studies. However, the mechanism of carcinogenesis by HCV is poorly understood. Unlike other human oncogenic viruses, HCV is a typical RNA virus, and thus there is no integration of the viral genome or a piece of the genome into host chromosomes. Moreover, transacting transcriptional factors which are coded by other human oncogenic viruses and required primarily for virus replication and often involve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
23
0

Year Published

1997
1997
2004
2004

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(23 citation statements)
references
References 29 publications
0
23
0
Order By: Relevance
“…Hepatitis C virus (HCV) infection is highly prevalent world-wide and is characterized by a very high rate (70 ± 80%) of progression to a chronic carrier state, as well as a risk of developing liver cirrhosis and hepatocellular carcinoma (HCC) (Lai and Ware, 2000;Shimotohno, 1995Shimotohno, , 2000. The molecular basis for the frequent resistance of HCV to interferon a (IFNa) therapy is poorly understood (see reviews in Brechot, 1998;McHutchison and Poynard, 1999;Sarrazin and Zeuzem, 1999).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hepatitis C virus (HCV) infection is highly prevalent world-wide and is characterized by a very high rate (70 ± 80%) of progression to a chronic carrier state, as well as a risk of developing liver cirrhosis and hepatocellular carcinoma (HCC) (Lai and Ware, 2000;Shimotohno, 1995Shimotohno, , 2000. The molecular basis for the frequent resistance of HCV to interferon a (IFNa) therapy is poorly understood (see reviews in Brechot, 1998;McHutchison and Poynard, 1999;Sarrazin and Zeuzem, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…Hepatocellular carcinoma is a long term complication of HCV infection, the tumor developing about 10 ± 20 years after acute infection as a complication of liver cirrhosis (see review in Shimotohno, 1995Shimotohno, , 2000. Chronic liver in¯ammation and ®brosis, the major histological features of chronic active hepatitis and cirrhosis, are major mechanisms of HCV-related liver carcinogenesis; there is also some evidence for a direct modulation of liver cell viability and proliferation by HCV protein expression, such as the viral core, E2 NS3 and NS5A proteins (reviews in Lai and Ware, 2000;McLauchlan, 2000;Tsuchihara et al, 1999, Neddermann et al, 1997.…”
Section: Introductionmentioning
confidence: 99%
“…1 Persistent HCV infection, which develops in at least 70% to 80% of infected patients, often progresses to chronic hepatitis and is highly correlated with the development of cirrhosis and hepatocellular carcinoma. [2][3][4] Neither a vaccine, nor effective therapy are currently available for HCV, other than interferon alfa combined with ribavirin. 5,6 HCV is an enveloped virus belonging to the Flaviviridae family.…”
mentioning
confidence: 99%
“…Hepatitis C Virus (HCV) 1 is the major cause of transfusionand community-acquired non-A, non-B hepatitis (1)(2)(3), often leading to cirrhosis of the liver, hepatocellular carcinoma (3)(4)(5), and some autoimmune diseases (6 -10). HCV is an enveloped, single-stranded, positive-sensed RNA virus.…”
mentioning
confidence: 99%